Stay updated on Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0; the page content remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:41:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide notice about NIH’s terminology transition was added above the site navigation. The clinical trial record still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:52:46.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T15:46:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error, with the footer revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T15:40:17.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with a Home button, signaling restricted access to the study record URL.
    Difference
    0.5%
    Check dated 2026-09-26T17:31:22.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error with a minimal header and navigation; the previously visible study details and related content are no longer accessible.
    Difference
    19%
    Check dated 2026-09-19T19:22:17.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page.